BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Recombinant Paenibacillus thiaminolyticus β-galactosidase 35A produced by Escherichia coli, is a crucial enzyme in the human body and is responsible for hydrolyzing galactosides into galactose.
Expression System
Escherichia coli
Species
Paenibacillus thiaminolyticus
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
β-Galactosidases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Paenibacillus thiaminolyticus β-galactosidase 35A is applied for the structural research of sugar, the measurement of lactose, and as an enzyme label for enzyme immunoassay. It has the ability to hydrolyze 4-nitrophenyl-β-D-fucopyranoside, 4-nitrophenyl-β-D-galactopyranoside, 4-nitrophenyl-β-D-glucopyranoside (PNPG), lactose.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.